Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2013 Jul 25;2013:bcr2013010179. doi: 10.1136/bcr-2013-010179

Radiographic illusion of cardiomegaly resulting from a pulmonary blastoma in a patient imaged for evaluation of chronic bronchitis

Swaroop Revannasiddaiah 1, Bhaskar Bhardwaj 2, Sridhar Papaiah Susheela 3, Shivaprakash Basavanthaiah Hiremath 4
PMCID: PMC3736289  PMID: 23887987

Description

Cardiomegaly is conveniently defined by a simple and time-tested method, using a posteroanterior chest radiograph obtained in mid-inspiration, as a ‘cardiothoracic ratio greater than 0.5’. The cardiothoracic ratio is in turn calculated by measuring the distance from the midline to the most lateral aspect of the left and right cardiac silhouette borders, and dividing the sum by the maximum horizontal measurement of the thorax, from the left to right pleural surface at the level of the diaphragmatic apices.1

The accompanying images belong to a man who presented with symptoms of dyspnoea, cough and thoracic pain. The patient had earlier been diagnosed to be suffering from chronic bronchitis. On the assumption of an acute exacerbation of chronic bronchitis, a chest radiograph (figure 1) was obtained as part of the initial evaluation. Surprisingly, the radiograph seemed to depict an enlarged cardiac silhouette, which by appearance happened to fulfil the Danzer criteria for assigning a radiological diagnosis of ‘cardiomegaly’.1

Figure 1.

Figure 1

Posteroanterior chest radiograph demonstrating the appearance of an enlarged cardiac silhouette.

However, further evaluation with sectional imaging (figure 2) demonstrated the cause behind the illusion of ‘cardiomegaly’ to be a solid mass lesion located posterolateral to the heart. Biopsy revealed the histopathology to be consistent with a biphasic-pulmonary blastoma, which are called so since they demonstrate the presence of both epithelial and mesenchymal components. Positive staining was noted for pan-cytokeratin, desmin, vimentin and epithelial membrane antigen. Subsequent to surgical resection, further treatment was with adjuvant chemotherapy based on dacarbazine and doxorubicin. At a follow-up of 2 years, the patient remains free of disease.

Figure 2.

Figure 2

Visualisation on an axial CT slice of the solid mass lesion situated posterior and lateral to the heart.

Learning points.

  • The cardiothoracic ratio (on a posteroanterior view thoracic radiograph obtained in inspiration) is calculated by measuring the distance from the midline to the most lateral aspect of the left and right cardiac silhouette borders (left apical and right atrial silhouettes), and dividing the sum by the maximum horizontal measurement of the thorax, from the left to right pleural surface at the level of the diaphragmatic apices. In rare situations, a mass lesion situated posterior/adjacent to the heart may be a differential diagnosis to (pseudo)cardiomegaly as visualised on a chest radiograph.

  • Pulmonary blastomas are rare tumours (accounting for 0.25–0.5% of all adult lung malignancies) and the sparse evidence available from case reports and series points towards initial surgical resection with adjuvant chemotherapy based on doxorubicin and dacarbazine as being the mainstay of optimal treatment.2 3

Footnotes

Contributors: SR initiated the article and provided the images. BB and SBH wrote the manuscript. HB performed the literature search. SPS finalised the article.

Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Danzer CS. The cardiothoracic ratio. Am J Med Sci 1919;2013:513–21 [Google Scholar]
  • 2.Koss MN, Hochholzer L, O'Leary T. Pulmonary blastomas. Cancer 1991;2013: 2368–81 [DOI] [PubMed] [Google Scholar]
  • 3.Van Loo S, Boeykens E, Stappaerts I, et al. Classic biphasic pulmonary blastoma: a case report and review of the literature. Lung Cancer 2011;2013:127–32 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES